FMI
LGND icon

F/M Investments’s Ligand Pharmaceuticals LGND Stock Holding History

F/M Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Sell
2,001
-44,129
-96% -$8.73M 0.03% 255
2025
Q4 		$8.72M Sell
46,130
-5,346
-10% -$1.03M 0.33% 70
2025
Q3 		$9.12M Sell
51,476
-1,031
-2% -$153K 0.35% 67
2025
Q2 		$5.97M Buy
52,507
+262
+0.5% +$28K 0.22% 95
2025
Q1 		$5.49M Sell
52,245
-638
-1% -$72.1K 0.22% 90
2024
Q4 		$5.67M Sell
52,883
-81,416
-61% -$9.2M 0.21% 102
2024
Q3 		$13.4M Sell
134,299
-411
-0.3% -$41.4K 0.42% 62
2024
Q2 		$11.4M Buy
+134,710
New +$10.7M 0.41% 68

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

F/M Investments's LGND Position: Q1 2026 in Review

F/M Investments reduced its Ligand Pharmaceuticals (LGND) stake by 96% in Q1 2026, selling an estimated $8.73M and leaving 2,001 shares worth $399K. The position accounts for 0.03% of the portfolio, ranked #255.

F/M Investments first reported a position in LGND in Q2 2024 and has held it in 8 quarters since. The position peaked at $13.4M in Q3 2024. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • F/M Investments held 2,001 shares of Ligand Pharmaceuticals worth $399K as of Q1 2026.
  • F/M Investments sold 44,129 Ligand Pharmaceuticals shares in Q1 2026, an estimated $8.73M.
  • Ligand Pharmaceuticals made up 0.03% of F/M Investments's portfolio in Q1 2026, its #255 holding.
  • F/M Investments first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • F/M Investments's Ligand Pharmaceuticals position peaked at $13.4M in Q3 2024.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.